EPOCH and Rituximab to Treat Non-Hodgkin's Lymphoma in Patients With HIV Infection | MicrobiomeTrials← Back to trialsNCT00006436
EPOCH and Rituximab to Treat Non-Hodgkin's Lymphoma in Patients With HIV Infection
CompletedPHASE2INTERVENTIONAL
Trial Details
Start: 2001-01-29Est. Completion: 2020-11-30
Enrollment target: 68 participants Locations- National Institutes of Health Clinical Center, 9000 Rockville Pike, Bethesda, Maryland, United States
Other microbiome trials you might be interested in
HIVKaposi's SarcomaLymphomasMulticentric Castleman's DiseasePrimary Effusion Lymphoma
BACKGROUND:
* A number of important scientific advances can be made through the study of blood, bone marrow, tumor, or …
Bethesda, United States
AIDS-related Non-Hodgkin LymphomaAIDS-related Plasmablastic LymphomaAIDS-related Primary Effusion LymphomaHIV Infection
This pilot clinical trial studies gene therapy after frontline chemotherapy in treating patients with acquired immune de…
Duarte, United StatesEst. completion Jul 6, 2027
Idiopathic CD4+ LymphocytopeniaCryptococcal MeningitisWarts
Background:
* Idiopathic CD4+ lymphocytopenia (ICL) is a condition in which there is a decreased level of CD4+ lymphocy…
Bethesda, United States